2nd Edition of Cell & Gene Therapy World Conference 2026
Scientific Committee
Mary Schaheen
Mary Schaheen
- Designation: President of Prevail Partners LLC
- Country: USA
Biography
Mary Schaheen is a strategic life sciences investor and accomplished business executive. As president of Prevail Partners LLC, she has built a powerful network of over 3,000 C-level and senior executives across the global life sciences industry. Through a hands-on, partnership-driven approach, she has positioned Prevail Partners as a force multiplier and risk reducer for its portfolio companies, actively supporting funding strategies, asset monetization, and exit pathways. Under her leadership, Prevail Partners has participated in over $10 billion in exits and licensing transactions, and has been involved in multiple IPOs within the past year. Mary and her team specialize in identifying high-potential clinical-stage therapeutics, both US and non-US, and maintain a growing interest in implantable medical devices. With a strong foundation in strategic capital deployment and deep industry connectivity, Mary brings more than capital, she brings a track record of execution, long-term vision, and trusted relationships that drive value across the biotech ecosystem.
Abstract
TBA
The 2nd Edition of Cell & Gene Therapy World Conference (CGTWC 2026) is one of those leading events that would stand high in biology and medical science. CGTWC 2026 will be held in ...
Read More>>
Organizer
